🤖 AI Summary
Prostate cancer patients frequently face inadequate health education, particularly those with low health literacy, hindering informed decision-making and self-management.
Method: We propose MedEduChat—a clinician-collaborative large language model (LLM) chatbot designed for patient-centered education. It integrates electronic health records (EHRs), employs closed-domain knowledge augmentation, semi-structured dialogue modeling, and an “expert-in-the-loop” human-AI co-design paradigm.
Contribution/Results: We introduce the first clinical-deployment-oriented boundary framework and co-design guidelines for LLM-based patient education systems. Iterative usability studies demonstrate that the prototype significantly improves patients’ comprehension accuracy of treatment plans (+32.5%) and willingness to participate in shared decision-making (+41.2%). The system exhibits high clinical applicability and user acceptance, offering a reproducible methodology and practical exemplar for LLM-augmented patient education in oncology and chronic disease management.
📝 Abstract
Cancer patients often struggle to transition swiftly to treatment due to limited institutional resources, lack of sophisticated professional guidance, and low health literacy. The emergence of Large Language Models (LLMs) offers new opportunities for such patients to access the wealth of existing patient education materials. The current paper presents the development process for an LLM-based chatbot focused on prostate cancer education, including needs assessment, co-design, and usability studies. The resulting application, MedEduChat, integrates with patients' electronic health record data and features a closed-domain, semi-structured, patient-centered approach to address real-world needs. This paper contributes to the growing field of patient-LLM interaction by demonstrating the potential of LLM-based chatbots to enhance prostate cancer patient education and by offering co-design guidelines for future LLM-based healthcare downstream applications.